Sorrento Therapeutics Inc.

11/29/2021 | Press release | Distributed by Public on 11/29/2021 08:36

Sorrento Publishes an Abivertinib Teaser Entitled “Abivertinib – a Franchise Oral Therapeutic For Cancer, Covid-19 And Autoimmune Diseases